[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.201.14. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1978

Granulocyte-Complement Interaction: A Beneficial Antimicrobial Mechanism That Can Cause Disease

Author Affiliations

From the Hematology Section, Department of Medicine, University of Minnesota Medical School, Minneapolis.

Arch Intern Med. 1978;138(3):461-463. doi:10.1001/archinte.1978.03630270075026
Abstract

As is so frequently the case, "experiments of nature," in which patients lack a normal bodily constituent, educate us to the function of the missing component. Although the plasma complement (C) system was initially recognized by its ability to foster hemolysis of antibody-coated RBCs, the microbicidal activity of the system probably has determined its evolutionary selection. Thus, rare patients who are genetically deficient in C3, a C component that is common to both pathways of C activation—the classical and alternative, are chronically and severely victimized by pyogenic infections.1

BENEFICIAL EFFECTS OF COMPLEMENT-GRANULOCYTE INTERACTION  The C system probably serves mainly to potentiate the capability of granulocytes to kill bacteria, and does so in several different ways. Perhaps most noteworthy is the ability of C3b, a cleavage product that results from activation of C3, to opsonize bacteria and other unwanted particles. Since granulocytes (and monocytes) have receptors for this and other

×